Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.

Ribeiro R, Monteiro C, Catalán V, Hu P, Cunha V, Rodríguez A, Gómez-Ambrosi J, Fraga A, Príncipe P, Lobato C, Lobo F, Morais A, Silva V, Sanches-Magalhães J, Oliveira J, Pina F, Lopes C, Medeiros R, Frühbeck G.

BMC Med. 2012 Sep 25;10:108. doi: 10.1186/1741-7015-10-108.

2.

Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro.

Ribeiro R, Monteiro C, Cunha V, Oliveira MJ, Freitas M, Fraga A, Príncipe P, Lobato C, Lobo F, Morais A, Silva V, Sanches-Magalhães J, Oliveira J, Pina F, Mota-Pinto A, Lopes C, Medeiros R.

J Exp Clin Cancer Res. 2012 Apr 2;31:32. doi: 10.1186/1756-9966-31-32.

3.
4.

Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma.

Ribeiro R, Monteiro C, Silvestre R, Castela A, Coutinho H, Fraga A, Príncipe P, Lobato C, Costa C, Cordeiro-da-Silva A, Lopes JM, Lopes C, Medeiros R.

Exp Biol Med (Maywood). 2012 Oct;237(10):1155-62. doi: 10.1258/ebm.2012.012131. Epub 2012 Oct 4.

PMID:
23038706
5.

Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study.

Venkatasubramanian PN, Brendler CB, Plunkett BA, Crawford SE, Fitchev PS, Morgan G, Cornwell ML, McGuire MS, Wyrwicz AM, Doll JA.

Prostate. 2014 Feb;74(3):326-35.

PMID:
24571013
6.

Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness.

Finley DS, Calvert VS, Inokuchi J, Lau A, Narula N, Petricoin EF, Zaldivar F, Santos R, Tyson DR, Ornstein DK.

J Urol. 2009 Oct;182(4):1621-7. doi: 10.1016/j.juro.2009.06.015. Epub 2009 Aug 15.

PMID:
19683746
7.

Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?

Zulian A, Cancello R, Micheletto G, Gentilini D, Gilardini L, Danelli P, Invitti C.

Gut. 2012 Jan;61(1):86-94. doi: 10.1136/gutjnl-2011-300391. Epub 2011 Sep 19.

PMID:
21930728
8.

Influence of adipocytokines and periprostatic adiposity measurement parameters on prostate cancer aggressiveness.

Zhang Q, Sun LJ, Qi J, Yang ZG, Huang T.

Asian Pac J Cancer Prev. 2014;15(4):1879-83.

9.

[Dissemination of prostate cancer: a way paved of fat].

Laurent V, Guérard A, Toulet A, Valet P, Malavaud B, Muller C.

Med Sci (Paris). 2016 Jun-Jul;32(6-7):563-5. doi: 10.1051/medsci/20163206012. Epub 2016 Jul 12. French. No abstract available.

10.

Periprostatic adipose tissue and prostate cancer progression: new insights into the tumor microenvironment.

Toren P, Venkateswaran V.

Clin Genitourin Cancer. 2014 Feb;12(1):21-6. doi: 10.1016/j.clgc.2013.07.013. Epub 2013 Oct 24. Review. No abstract available.

PMID:
24269373
11.

Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population.

Chen JH, He HC, Jiang FN, Militar J, Ran PY, Qin GQ, Cai C, Chen XB, Zhao J, Mo ZY, Chen YR, Zhu JG, Liu X, Zhong WD.

Med Oncol. 2012 Sep;29(3):1972-84. doi: 10.1007/s12032-011-0088-5. Epub 2011 Oct 30.

PMID:
22038724
12.

A stratified transcriptomics analysis of polygenic fat and lean mouse adipose tissues identifies novel candidate obesity genes.

Morton NM, Nelson YB, Michailidou Z, Di Rollo EM, Ramage L, Hadoke PW, Seckl JR, Bunger L, Horvat S, Kenyon CJ, Dunbar DR.

PLoS One. 2011;6(9):e23944. doi: 10.1371/journal.pone.0023944. Epub 2011 Sep 7.

13.

[Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].

Qu YY, Dai B, Chang K, Kong YY, Gu CY, Zhang GM, Wan FN, Wang HK, Zhang HL, Zhu Y, Ye DW.

Zhonghua Wai Ke Za Zhi. 2013 Dec;51(12):1089-93. Chinese.

PMID:
24499718
14.

MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness.

Iordanescu G, Brendler C, Crawford SE, Wyrwicz AM, Venkatasubramanian PN, Doll JA.

J Magn Reson Imaging. 2015 Sep;42(3):651-7. doi: 10.1002/jmri.24824. Epub 2014 Dec 19.

PMID:
25522916
15.

Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: distinct expression of cell-cycle- and differentiation-related genes.

Rodríguez-Acebes S, Palacios N, Botella-Carretero JI, Olea N, Crespo L, Peromingo R, Gómez-Coronado D, Lasunción MA, Vázquez C, Martínez-Botas J.

BMC Med Genomics. 2010 Dec 23;3:61. doi: 10.1186/1755-8794-3-61.

16.

Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy.

Allott EH, Howard LE, Song HJ, Sourbeer KN, Koontz BF, Salama JK, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2404-12. doi: 10.1158/1055-9965.EPI-14-0236. Epub 2014 Aug 21.

17.

[The relationship between oxidative stress and obesity in prostate disease].

Scavuzzo A, Favilla V, Cimino S, Madonia M, Li Volti G, Morgia G.

Urologia. 2012 Apr-Jun;79(2):156-8. doi: 10.5301/RU.2012.9206. Italian.

18.

Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients.

van Roermund JG, Hinnen KA, Tolman CJ, Bol GH, Witjes JA, Bosch JL, Kiemeney LA, van Vulpen M.

BJU Int. 2011 Jun;107(11):1775-9. doi: 10.1111/j.1464-410X.2010.09811.x. Epub 2010 Nov 2.

19.

Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.

Myers JS, von Lersner AK, Robbins CJ, Sang QX.

PLoS One. 2015 Dec 18;10(12):e0145322. doi: 10.1371/journal.pone.0145322. eCollection 2015.

20.

Subcutaneous and gonadal adipose tissue transcriptome differences in lean and obese female dogs.

Grant RW, Vester Boler BM, Ridge TK, Graves TK, Swanson KS.

Anim Genet. 2013 Dec;44(6):728-35. doi: 10.1111/age.12060. Epub 2013 May 29.

PMID:
23713485

Supplemental Content

Support Center